# Nextnav Inc.: financial statements, quarterly

NN · Nasdaq · CIK 1865631 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/nn.md) · [Financials](/companies/nn/financials.md) · [Filings](/companies/nn/filings.md) · [Insiders](/companies/nn/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/nn/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1.0](/filings/0001213900-24-097473.md) | [1.2 d](/filings/0001213900-25-023287.md) | [1.0](/filings/0001213900-25-041217.md) | [1.1](/filings/0001554855-25-000923.md) | [1.6](/filings/0001554855-25-001955.md) | [1.9 d](/filings/0001554855-26-000328.md) | [1.5](/filings/0001554855-26-001046.md) | [1.2](/filings/0001554855-26-001789.md) | [0.9](/filings/0001554855-25-001955.md) | [0.9 d](/filings/0001554855-26-000328.md) | [1.0](/filings/0001554855-26-001046.md) | [1.2](/filings/0001554855-26-001789.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Research and development | $m | [5.0](/filings/0001213900-24-097473.md) | [4.9 d](/filings/0001213900-25-023287.md) | [4.7](/filings/0001213900-25-041217.md) | [4.1](/filings/0001554855-25-000923.md) | [3.5](/filings/0001554855-25-001955.md) | [3.9 d](/filings/0001554855-26-000328.md) | [4.0](/filings/0001554855-26-001046.md) | [4.8](/filings/0001554855-26-001789.md) | [5.2](/filings/0001554855-25-001955.md) | [4.9 d](/filings/0001554855-26-000328.md) | [5.9](/filings/0001554855-26-001046.md) | [5.5](/filings/0001554855-26-001789.md) |
| Selling, general and administrative | $m | [6.2](/filings/0001213900-24-097473.md) | [11.6 d](/filings/0001213900-25-023287.md) | [8.4](/filings/0001213900-25-041217.md) | [8.1](/filings/0001554855-25-000923.md) | [8.0](/filings/0001554855-25-001955.md) | [8.9 d](/filings/0001554855-26-000328.md) | [10.5](/filings/0001554855-26-001046.md) | [10.2](/filings/0001554855-26-001789.md) | [10.0](/filings/0001554855-25-001955.md) | [8.8 d](/filings/0001554855-26-000328.md) | [10.7](/filings/0001554855-26-001046.md) | [12.6](/filings/0001554855-26-001789.md) |
| Operating income | $m | [(14.6)](/filings/0001213900-24-097473.md) | [(19.9) d](/filings/0001213900-25-023287.md) | [(16.2)](/filings/0001213900-25-041217.md) | [(15.3)](/filings/0001554855-25-000923.md) | [(13.9)](/filings/0001554855-25-001955.md) | [(14.8) d](/filings/0001554855-26-000328.md) | [(17.0)](/filings/0001554855-26-001046.md) | [(17.2)](/filings/0001554855-26-001789.md) | [(19.9)](/filings/0001554855-25-001955.md) | [(16.1) d](/filings/0001554855-26-000328.md) | [(19.3)](/filings/0001554855-26-001046.md) | [(20.2)](/filings/0001554855-26-001789.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | [0.2](/filings/0001554855-26-001046.md) | [4.9](/filings/0001554855-26-001789.md) | [5.0](/filings/0001554855-25-001955.md) | not reported | [5.2](/filings/0001554855-26-001046.md) | [4.4](/filings/0001554855-26-001789.md) |
| Income tax | $m | [0.0](/filings/0001213900-24-097473.md) | [0.1 d](/filings/0001213900-25-023287.md) | [0.0](/filings/0001213900-25-041217.md) | [0.1](/filings/0001554855-25-000923.md) | [0.0](/filings/0001554855-25-001955.md) | [0.0 d](/filings/0001554855-26-000328.md) | [0.1](/filings/0001554855-26-001046.md) | [0.0](/filings/0001554855-26-001789.md) | [0.0](/filings/0001554855-25-001955.md) | [0.1 d](/filings/0001554855-26-000328.md) | [0.1](/filings/0001554855-26-001046.md) | [0.1](/filings/0001554855-26-001789.md) |
| Net income | $m | [(23.2)](/filings/0001213900-24-097473.md) | [(16.4) d](/filings/0001213900-25-023287.md) | [(31.6)](/filings/0001554855-25-001955.md) | [(24.4)](/filings/0001554855-25-001955.md) | [(13.6)](/filings/0001554855-25-001955.md) | [(32.3) d](/filings/0001554855-26-000328.md) | [(58.6)](/filings/0001554855-26-001046.md) | [(63.2)](/filings/0001554855-26-001789.md) | [0.5](/filings/0001554855-25-001955.md) | [(68.0) d](/filings/0001554855-26-000328.md) | [(10.6)](/filings/0001554855-26-001046.md) | [(33.8)](/filings/0001554855-26-001789.md) |
| Diluted EPS | $ per share | [(0.21)](/filings/0001213900-24-097473.md) | not reported | [(0.28)](/filings/0001213900-25-041217.md) | [(0.21)](/filings/0001554855-25-000923.md) | [(0.11)](/filings/0001554855-25-001955.md) | not reported | [(0.45)](/filings/0001554855-26-001046.md) | [(0.48)](/filings/0001554855-26-001789.md) | [(0.12)](/filings/0001554855-25-001955.md) | not reported | [(0.12)](/filings/0001554855-26-001046.md) | [(0.24)](/filings/0001554855-26-001789.md) |
| Basic EPS | $ per share | [(0.21)](/filings/0001213900-24-097473.md) | not reported | [(0.28)](/filings/0001213900-25-041217.md) | [(0.21)](/filings/0001554855-25-000923.md) | [(0.11)](/filings/0001554855-25-001955.md) | not reported | [(0.45)](/filings/0001554855-26-001046.md) | [(0.48)](/filings/0001554855-26-001789.md) | [0.00](/filings/0001554855-25-001955.md) | not reported | [(0.08)](/filings/0001554855-26-001046.md) | [(0.24)](/filings/0001554855-26-001789.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: not reported
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [90.1](/filings/0001213900-23-084746.md) | [81.9](/filings/0001213900-24-097473.md) | [73.3](/filings/0001213900-24-040871.md) | [63.0](/filings/0001213900-24-066133.md) | [67.9](/filings/0001213900-24-097473.md) | [39.3](/filings/0001554855-25-001955.md) | [150](/filings/0001213900-25-041217.md) | [58.9](/filings/0001554855-25-000923.md) | [90.0](/filings/0001554855-25-001955.md) | [44.8](/filings/0001554855-26-001789.md) | [30.6](/filings/0001554855-26-001046.md) | [77.7](/filings/0001554855-26-001789.md) |
| Current assets | $m | [102](/filings/0001213900-23-084746.md) | [91.2](/filings/0001213900-25-023287.md) | [96.8](/filings/0001213900-24-040871.md) | [104](/filings/0001213900-24-066133.md) | [104](/filings/0001213900-24-097473.md) | [86.0](/filings/0001554855-26-000328.md) | [193](/filings/0001213900-25-041217.md) | [182](/filings/0001554855-25-000923.md) | [172](/filings/0001554855-25-001955.md) | [157](/filings/0001554855-26-001789.md) | [148](/filings/0001554855-26-001046.md) | [304](/filings/0001554855-26-001789.md) |
| Total assets | $m | [173](/filings/0001213900-23-084746.md) | [162](/filings/0001213900-25-023287.md) | [166](/filings/0001213900-24-040871.md) | [172](/filings/0001213900-24-066133.md) | [172](/filings/0001213900-24-097473.md) | [162](/filings/0001554855-26-000328.md) | [269](/filings/0001213900-25-041217.md) | [257](/filings/0001554855-25-000923.md) | [263](/filings/0001554855-25-001955.md) | [247](/filings/0001554855-26-001789.md) | [236](/filings/0001554855-26-001046.md) | [389](/filings/0001554855-26-001789.md) |
| Current liabilities | $m | [11.2](/filings/0001213900-23-084746.md) | [9.8](/filings/0001213900-25-023287.md) | [24.1](/filings/0001213900-24-040871.md) | [17.6](/filings/0001213900-24-066133.md) | [20.8](/filings/0001213900-24-097473.md) | [12.1](/filings/0001554855-26-000328.md) | [11.5](/filings/0001213900-25-041217.md) | [12.2](/filings/0001554855-25-000923.md) | [14.9](/filings/0001554855-25-001955.md) | [12.4](/filings/0001554855-26-001789.md) | [14.1](/filings/0001554855-26-001046.md) | [11.9](/filings/0001554855-26-001789.md) |
| Total liabilities | $m | [89.0](/filings/0001213900-23-084746.md) | [82.1](/filings/0001213900-25-023287.md) | [108](/filings/0001213900-24-040871.md) | [108](/filings/0001213900-24-066133.md) | [106](/filings/0001213900-24-097473.md) | [112](/filings/0001554855-26-000328.md) | [262](/filings/0001213900-25-041217.md) | [304](/filings/0001554855-25-000923.md) | [285](/filings/0001554855-25-001955.md) | [333](/filings/0001554855-26-001789.md) | [326](/filings/0001554855-26-001046.md) | [54.6](/filings/0001554855-26-001789.md) |
| Long-term debt | $m | [47.1](/filings/0001213900-23-084746.md) | [48.4](/filings/0001213900-25-023287.md) | [49.9](/filings/0001213900-24-040871.md) | [51.4](/filings/0001213900-24-066133.md) | [53.0](/filings/0001213900-24-097473.md) | [54.6](/filings/0001554855-26-000328.md) | [213](/filings/0001213900-25-041217.md) | [246](/filings/0001554855-25-000923.md) | [230](/filings/0001554855-25-001955.md) | [274](/filings/0001554855-26-001789.md) | [267](/filings/0001554855-26-001046.md) | not reported |
| Shareholders' equity | $m | [80.3](/filings/0001213900-23-084746.md) | [78.7](/filings/0001213900-25-023287.md) | [55.9](/filings/0001213900-24-040871.md) | [63.8](/filings/0001213900-24-066133.md) | [65.6](/filings/0001213900-24-097473.md) | [50.1](/filings/0001554855-26-000328.md) | [6.6](/filings/0001213900-25-041217.md) | [(47.2)](/filings/0001554855-25-000923.md) | [(22.1)](/filings/0001554855-25-001955.md) | [(86.2)](/filings/0001554855-26-001789.md) | [(90.0)](/filings/0001554855-26-001046.md) | [335](/filings/0001554855-26-001789.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(8.7) d](/filings/0001213900-24-097473.md) | [(10.8) d](/filings/0001213900-25-023287.md) | [(7.0)](/filings/0001213900-25-041217.md) | [(12.3) d](/filings/0001554855-25-000923.md) | [(6.8) d](/filings/0001554855-25-001955.md) | [(11.9) d](/filings/0001554855-26-000328.md) | [(12.2)](/filings/0001554855-26-001046.md) | [(13.5) d](/filings/0001554855-26-001789.md) | [(9.0) d](/filings/0001554855-25-001955.md) | [(16.1) d](/filings/0001554855-26-000328.md) | [(10.0)](/filings/0001554855-26-001046.md) | [(18.0) d](/filings/0001554855-26-001789.md) |
| Capital expenditure | $m | [0.2 d](/filings/0001213900-24-097473.md) | [0.2 d](/filings/0001213900-25-023287.md) | [0.0](/filings/0001213900-25-041217.md) | [0.1 d](/filings/0001554855-25-000923.md) | [0.0 d](/filings/0001554855-25-001955.md) | [0.2 d](/filings/0001554855-26-000328.md) | [0.0](/filings/0001554855-26-001046.md) | [0.0 d](/filings/0001554855-26-001789.md) | [0.0 d](/filings/0001554855-25-001955.md) | [(0.0) d](/filings/0001554855-26-000328.md) | [0.0](/filings/0001554855-26-001046.md) | [0.0 d](/filings/0001554855-26-001789.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [101](/filings/0001213900-23-084746.md) | [0.1](/filings/0001213900-24-040871.md) | [0.1](/filings/0001213900-24-066133.md) | [0.1](/filings/0001213900-24-097473.md) | [111](/filings/0001213900-25-041217.md) | [115](/filings/0001554855-25-000923.md) | [126](/filings/0001554855-25-001955.md) | [131](/filings/0001554855-26-001046.md) | [132](/filings/0001554855-26-001789.md) | [150](/filings/0001554855-25-001955.md) | [152](/filings/0001554855-26-001046.md) | [142](/filings/0001554855-26-001789.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 168,809,910 at 2026-08-07, from the cover of the [10-Q filed 2026-08-11](/filings/0001554855-26-001789.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.